Medtronic Cardiac Rhythm and Heart Failure

medtronic.com

Total trials

263

Active

11

Phase 3

5

Total enrollment

171,645

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 0 of 0 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal

Next readouts

No upcoming readouts found.

Top conditions

  • Heart Failure78
  • Bradycardia21
  • Atrial Fibrillation21
  • Ventricular Fibrillation10
  • Aortic Valve Stenosis9
  • Arrhythmia9
  • Tachycardia9
  • Chronic Heart Failure7

Frequently asked questions about Medtronic Cardiac Rhythm and Heart Failure

How many clinical trials does Medtronic Cardiac Rhythm and Heart Failure have on ClinicalTrials.gov?
Medtronic Cardiac Rhythm and Heart Failure is listed as the lead sponsor on 263 clinical trials in ClinicalTrials.gov, 11 of which are currently active (recruiting, enrolling, or ongoing).
How many of Medtronic Cardiac Rhythm and Heart Failure's trials are in Phase 3?
5 of Medtronic Cardiac Rhythm and Heart Failure's trials are in Phase 3.
What therapeutic areas does Medtronic Cardiac Rhythm and Heart Failure focus on?
Medtronic Cardiac Rhythm and Heart Failure's most-studied conditions on ClinicalTrials.gov are Heart Failure, Bradycardia, Atrial Fibrillation, Ventricular Fibrillation, Aortic Valve Stenosis.